Alcon AG vs SK Hynix — how do they compare? Alcon AG trades at $66.03 (market cap $32.08B), while SK Hynix trades at $190.07 (market cap $952.66B). The key difference: SK Hynix is far larger — about 29.7× Alcon AG's market cap, and Alcon AG pays a 0.54% dividend while SK Hynix pays none. Which is the better fit depends on your goals.
| ALC | SKHY | |
|---|---|---|
Market Cap | $32.08B | $952.66B |
Sector | Health | Technology |
52-Week High | $87.18 | $198.63 |
52-Week Low | $62.02 | $126.79 |
Enterprise Value | $35.92B | $903.14B |
Dividend Yield | 0.54% | — |
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.03, down 0.78% today, with a bearish technical signal from moving averages but bullish oscillators. Revenue grew to $10.40B in 2025, though net income dipped to $980M. Recent Q2 2026 earnings beat expectations, and the company raised its 2026 profit outlook. Analyst consensus is bullish with a $85.85 price target, supported by new product launches and tariff relief.
Outlook is positive due to strong analyst support and operational execution, but risks include intense competition and margin pressure. The stock offers potential upside to the price target, though investors should monitor earnings consistency and macroeconomic headwinds.
SKHY trades at $190.07, up 0.94% with strong technical momentum showing bullish moving averages and key support at $186. The company demonstrates exceptional profitability with 85.62% net income margin and 92.68% ROE, while consistently beating earnings estimates in recent quarters. Recent news highlights SKHY's leadership in AI memory chips with 50% HBM market share and strong institutional support.
Outlook remains positive with 100% analyst buy ratings and $248 consensus target suggesting 30% upside. Key risks include market volatility from oil price inflation pressures and competitive dynamics in the semiconductor sector. The stock's attractive valuation at 11.2 P/E combined with AI-driven growth creates compelling investment opportunity.
Trailing returns across standard periods
Latest headlines on both assets
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →SK hynix is a South Korean semiconductor company that manufactures memory products, including DRAM and NAND flash. Its high-bandwidth memory (HBM) products are designed for high-performance computing and AI applications.
Read more on SKHY →